If transaction data for a specialty medication order is not provided by the wholesaler, what is an appropriate immediate action?

• A. Quarantine the product and contact the wholesaler, and review the data when it is provided.
• B. Ignore the issue and fulfill the order.
• C. Put the product into active stock immediately.
• D. Return the product to the wholesaler without review.

Answer: (A)

When you’re dealing with a specialty medication, knowing where a product has come from and its journey through the supply chain is crucial. If the wholesaler can’t provide transaction data for the order, the immediate step is to quarantine the product, contact the wholesaler to obtain the missing data, and review it as soon as it arrives. This protects patient safety and regulatory compliance because the transaction data confirm the product’s origin, lot number, expiration, and chain of custody, preventing counterfeit or diverted meds from entering patient care.

Only after you verify the missing information should you release the product into inventory or fulfill the order. Ignoring the data, stocking without verification, or returning the item without review could expose the pharmacy to regulatory penalties and patient safety risks. Returning without verification is not a substitute for obtaining and checking the data.